Business Description
Modern Chinese Medicine Group Co Ltd
ISIN : KYG6181B1068
Share Class Description:
HKSE:01643: Ordinary SharesCompare
Compare
Traded in other countries / regions
01643.Hong Kong IPO Date
2021-01-15Description
Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3963.44 | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | 14955.8 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.64 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.4 | |||||
| 3-Year EBITDA Growth Rate | 25 | |||||
| 3-Year EPS without NRI Growth Rate | 23.8 | |||||
| 3-Year FCF Growth Rate | 44.7 | |||||
| 3-Year Book Growth Rate | 83.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 94.94 | |||||
| 9-Day RSI | 82.43 | |||||
| 14-Day RSI | 70.63 | |||||
| 6-1 Month Momentum % | -12.33 | |||||
| 12-1 Month Momentum % | -33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.93 | |||||
| Quick Ratio | 7.98 | |||||
| Cash Ratio | 5.86 | |||||
| Days Inventory | 64.9 | |||||
| Days Sales Outstanding | 92.57 | |||||
| Days Payable | 44.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.03 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.28 | |||||
| Operating Margin % | 19.87 | |||||
| Net Margin % | 14.18 | |||||
| FCF Margin % | 0.98 | |||||
| ROE % | 10.78 | |||||
| ROA % | 9.51 | |||||
| ROIC % | 26.82 | |||||
| ROC (Joel Greenblatt) % | 41.11 | |||||
| ROCE % | 14.89 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 4.04 | |||||
| PE Ratio without NRI | 4.04 | |||||
| Price-to-Owner-Earnings | 1.87 | |||||
| PEG Ratio | 0.15 | |||||
| PS Ratio | 0.57 | |||||
| PB Ratio | 0.42 | |||||
| Price-to-Tangible-Book | 0.42 | |||||
| Price-to-Free-Cash-Flow | 3.27 | |||||
| Price-to-Operating-Cash-Flow | 2.72 | |||||
| EV-to-EBIT | -1.17 | |||||
| EV-to-EBITDA | -1.17 | |||||
| EV-to-Revenue | -0.23 | |||||
| EV-to-FCF | -1.34 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.09 | |||||
| Price-to-Graham-Number | 0.27 | |||||
| Price-to-Net-Current-Asset-Value | 0.52 | |||||
| Price-to-Net-Cash | 0.86 | |||||
| Earnings Yield (Greenblatt) % | -85.47 | |||||
| FCF Yield % | 1.71 | |||||
| Forward Rate of Return (Yacktman) % | 39.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Modern Chinese Medicine Group Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 376.342 | ||
| EPS (TTM) (HK$) | 0.089 | ||
| Beta | 0.55 | ||
| Volatility % | 28.19 | ||
| 14-Day RSI | 70.63 | ||
| 14-Day ATR (HK$) | 0.012831 | ||
| 20-Day SMA (HK$) | 0.3235 | ||
| 12-1 Month Momentum % | -33.33 | ||
| 52-Week Range (HK$) | 0.29 - 0.53 | ||
| Shares Outstanding (Mil) | 600 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Modern Chinese Medicine Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Modern Chinese Medicine Group Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Modern Chinese Medicine Group Co Ltd Frequently Asked Questions
What is Modern Chinese Medicine Group Co Ltd(HKSE:01643)'s stock price today?
The current price of HKSE:01643 is HK$0.36. The 52 week high of HKSE:01643 is HK$0.53 and 52 week low is HK$0.29.
When is next earnings date of Modern Chinese Medicine Group Co Ltd(HKSE:01643)?
The next earnings date of Modern Chinese Medicine Group Co Ltd(HKSE:01643) is .
Does Modern Chinese Medicine Group Co Ltd(HKSE:01643) pay dividends? If so, how much?
Modern Chinese Medicine Group Co Ltd(HKSE:01643) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers